home / stock / espr / espr quote
Last: | $2.36 |
---|---|
Change Percent: | 0.0% |
Open: | $2.34 |
Close: | $2.36 |
High: | $2.405 |
Low: | $2.32 |
Volume: | 3,880,835 |
Last Trade Date Time: | 07/03/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$2.36 | $2.34 | $2.36 | $2.405 | $2.32 | 3,880,835 | 07-04-2024 |
$2.36 | $2.34 | $2.36 | $2.405 | $2.32 | 3,880,835 | 07-03-2024 |
$2.34 | $2.3 | $2.34 | $2.475 | $2.24 | 9,869,467 | 07-02-2024 |
$2.34 | $2.23 | $2.34 | $2.5 | $2.22 | 10,041,534 | 07-01-2024 |
$2.22 | $2.49 | $2.22 | $2.65 | $2.05 | 61,408,848 | 06-28-2024 |
$2.31 | $2.16 | $2.31 | $2.35 | $2.16 | 5,773,183 | 06-27-2024 |
$2.18 | $2.09 | $2.18 | $2.19 | $2.06 | 5,536,494 | 06-26-2024 |
$2.09 | $2.18 | $2.09 | $2.26 | $2.09 | 4,192,454 | 06-25-2024 |
$2.18 | $2.2 | $2.18 | $2.29 | $2.16 | 4,450,911 | 06-24-2024 |
$2.21 | $2.32 | $2.21 | $2.34 | $2.18 | 8,719,612 | 06-21-2024 |
$2.29 | $2.58 | $2.29 | $2.64 | $2.24 | 18,318,739 | 06-20-2024 |
$2.72 | $2.9 | $2.72 | $2.93 | $2.71 | 4,484,812 | 06-19-2024 |
$2.72 | $2.9 | $2.72 | $2.93 | $2.71 | 4,484,812 | 06-18-2024 |
$2.87 | $3.01 | $2.87 | $3.01 | $2.83 | 4,624,344 | 06-17-2024 |
$2.99 | $2.88 | $2.99 | $2.995 | $2.77 | 7,959,420 | 06-14-2024 |
$2.91 | $2.9 | $2.91 | $2.915 | $2.68 | 9,122,486 | 06-13-2024 |
$2.89 | $2.99 | $2.89 | $3.11 | $2.85 | 7,283,008 | 06-12-2024 |
$2.9 | $2.91 | $2.9 | $2.99 | $2.8631 | 6,080,400 | 06-11-2024 |
$2.91 | $2.79 | $2.91 | $3.12 | $2.77 | 14,900,440 | 06-10-2024 |
$2.8 | $2.42 | $2.8 | $2.85 | $2.41 | 14,283,260 | 06-07-2024 |
News, Short Squeeze, Breakout and More Instantly...
Esperion Therapeutics Inc. Company Name:
ESPR Stock Symbol:
NASDAQ Market:
Esperion Therapeutics Inc. Website:
– OMERS Life Sciences to Purchase Esperion’s European Royalty on Bempedoic Acid Products for $304.7 Million with European Royalties Reverting to Esperion Once OMERS Receives 1.7 Times its Investment – – Esperion Retains Rights to Receive all Poten...